drugset / Trial / NCT01435200

Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy

NCT01435200 ↗

Phase 3 Completed 64 enrolled Chulalongkorn University
RandomizedParallel-groupOpen-labelTreatment

Summary

Can intravenous iron lower the rate of blood transfusion in gynecologic cancer patients receiving platinum based chemotherapy than oral iron?

Timeline

Start
2011-06
Primary completion
2012-10
Completion
2012-11

Outcome

Met primary endpoint

paper Nine patients (28.1%) in the study group and 18 patients (56.3%) in the control group required blood transfusion through 6 cycles of chemotherapy (p=0.02). PMID 24099839 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown 200 mg Intravenous